Cargando…

MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer

BACKGROUND: Non-small cell lung cancer (NSCLC) is a leading cause of cancer death worldwide. Early diagnosis is essential for improvements of prognosis and survival of the patients. Currently, there is no effective biomarker available in clinical settings for early detection of lung cancer. Altered...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wanshuai, Wang, Yong, Zhang, Qi, Tang, Lili, Liu, Xiaoping, Dai, Yunhua, Xiao, Liang, Huang, Shuguang, Chen, Lu, Guo, Zhongmin, Lu, Jim, Yuan, Kai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4523212/ https://www.ncbi.nlm.nih.gov/pubmed/26237047 http://dx.doi.org/10.1371/journal.pone.0134220

Ejemplares similares

Correction: MicroRNA-486 as a Biomarker for Early Diagnosis and Recurrence of Non-Small Cell Lung Cancer
por: Li, Wanshuai, et al.
Publicado: (2016)

MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification
por: Fernández-Villabrille, Sara, et al.
Publicado: (2023)

Circulating MicroRNA-486 and MicroRNA-146a serve as potential biomarkers of sarcopenia in the older adults
por: Liu, Huang-Chun, et al.
Publicado: (2021)

MicroRNA-486-5p and microRNA-486-3p: Multifaceted pleiotropic mediators in oncological and non-oncological conditions
por: ElKhouly, Aisha M., et al.
Publicado: (2020)

The Anti-fibrotic Effects and Mechanisms of MicroRNA-486-5p in Pulmonary Fibrosis
por: Ji, Xiaoming, et al.
Publicado: (2015)

MicroRNA 486-3P as a stability marker in acute coronary syndrome
por: Wei, Tianling, et al.
Publicado: (2016)

miR-486 as an unfavorable prognostic biomarker for patients with non-small cell lung cancer
por: Gao, Zhao-Jia, et al.
Publicado: (2020)

Circ_0005320 promotes oral squamous cell carcinoma tumorigenesis by sponging microRNA-486-3p and microRNA-637
por: Zheng, Xiaotao, et al.
Publicado: (2021)

Salivary Exosomal MicroRNA-486-5p and MicroRNA-10b-5p in Oral and Oropharyngeal Squamous Cell Carcinoma
por: Faur, Cosmin Ioan, et al.
Publicado: (2022)

Muscle-enriched microRNA miR-486 decreases in circulation in response to exercise in young men
por: Aoi, Wataru, et al.
Publicado: (2013)

Overexpression of microRNA-486 affects the proliferation and chemosensitivity of mesothelioma cell lines by targeting PIM1
por: Pinelli, Silvana, et al.
Publicado: (2021)

Serum microRNAs as biomarkers for recurrence in melanoma
por: Friedman, Erica B, et al.
Publicado: (2012)

Propofol inhibits lung cancer cell viability and induces cell apoptosis by upregulating microRNA-486 expression
por: Yang, N., et al.
Publicado: (2017)

MicroRNA 486-3p directly targets BIK and regulates apoptosis and invasion in colorectal cancer cells
por: Feng, Li, et al.
Publicado: (2018)

MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1
por: Chou, Sung-Tau, et al.
Publicado: (2019)

Identification of microRNA-451a as a Novel Circulating Biomarker for Colorectal Cancer Diagnosis
por: Zhang, Zhen, et al.
Publicado: (2020)

Serum microRNA 143 and microRNA 215 as potential biomarkers for the diagnosis of chronic hepatitis and hepatocellular carcinoma
por: Zhang, Zhu-qing, et al.
Publicado: (2014)

MicroRNA-486-5p inhibits the growth of human hypertrophic scar fibroblasts by regulating Smad2 expression
por: Shi, Yingying, et al.
Publicado: (2019)

MicroRNA-486-5p Suppresses Lung Cancer via Downregulating mTOR Signaling In Vitro and In Vivo
por: Ding, Lei, et al.
Publicado: (2021)

Sertoli cell‐derived exosomal MicroRNA‐486‐5p regulates differentiation of spermatogonial stem cell through PTEN in mice
por: Li, Quan, et al.
Publicado: (2021)

MiR-486 as an effective biomarker in cancer diagnosis and prognosis: a systematic review and meta-analysis
por: Jiang, Min, et al.
Publicado: (2018)

Altered serum microRNAs as biomarkers for the early diagnosis of pulmonary tuberculosis infection
por: Qi, Yuhua, et al.
Publicado: (2012)

MicroRNA‐based biomarkers for diagnosis of non‐small cell lung cancer (NSCLC)
por: Liao, Jipei, et al.
Publicado: (2020)

Identification of microRNAs in Throat Swab as the Biomarkers for Diagnosis of Influenza
por: Peng, Fang, et al.
Publicado: (2016)

Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer
por: Du, Lutao, et al.
Publicado: (2017)

Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486
por: Xu, Jing, et al.
Publicado: (2012)

Long Non-Coding RNA LINC02802 Regulates In Vitro Sprouting Angiogenesis by Sponging microRNA-486-5p
por: Rosano, Stefania, et al.
Publicado: (2022)

Circ‐TCF4.85 silencing inhibits cancer progression through microRNA‐486‐5p‐targeted inhibition of ABCF2 in hepatocellular carcinoma
por: Gao, Jun, et al.
Publicado: (2020)

Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma
por: Zhang, Yanqing, et al.
Publicado: (2017)

MicroRNAs as Biomarkers for the Diagnosis of Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
por: Li, Jiangbi, et al.
Publicado: (2021)

microRNA-Based Biomarkers and the Diagnosis of Alzheimer’s Disease
por: Zhao, Yuhai, et al.
Publicado: (2015)

MicroRNA-486-3p Regulates γ-Globin Expression in Human Erythroid Cells by Directly Modulating BCL11A
por: Lulli, Valentina, et al.
Publicado: (2013)

Downregulated circulating microRNAs after surgery: potential noninvasive biomarkers for diagnosis and prognosis of early breast cancer
por: Wang, Yaohui, et al.
Publicado: (2018)

Plasma microRNAs as potential biomarkers for non-small-cell lung cancer
por: Shen, Jun, et al.
Publicado: (2011)

Depletion of erythropoietic miR-486-5p and miR-451a improves detectability of rare microRNAs in peripheral blood-derived small RNA sequencing libraries
por: Juzenas, Simonas, et al.
Publicado: (2020)

Potential role of circulating microRNAs (486-5p, 497, 509-5p and 605) in metabolic syndrome Egyptian male patients
por: Bakr Zaki, Mohamed, et al.
Publicado: (2019)

MicroRNAs as Biomarkers for Diagnosis, Prognosis and Theranostics in Prostate Cancer
por: Bertoli, Gloria, et al.
Publicado: (2016)

Emerging microRNA biomarkers for colorectal cancer diagnosis and prognosis
por: Chen, Bing, et al.
Publicado: (2019)

MicroRNA Signatures as Future Biomarkers for Diagnosis of Diabetes States
por: Vasu, Srividya, et al.
Publicado: (2019)

Multiple microRNAs as biomarkers for early breast cancer diagnosis
por: Jang, Ji Young, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_roroqr3cj2d8a9b96b59ct2r1n